Aclaris Therapeutics, Inc. (ACRS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.1700 |
| Open | 1.1800 |
| Bid | 1.1400 x 100 |
| Ask | 1.1900 x 1000 |
| Day's Range | 1.1650 - 1.2000 |
| 52 Week Range | 0.5900 - 7.5400 |
| Volume | |
| Avg. Volume | 763,103 |
| Market Cap | 84.187M |
| Beta (5Y Monthly) | 0.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.8200 |
| Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.55 |
GlobeNewswireAclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
WAYNE, Pa., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that members of the Aclaris management team will participate in a fireside chat during the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024 at 8:00 AM ET in New York, New York. A webcast of the fireside chat may be accessed through the “Events” page
Simply Wall St.Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
A week ago, Aclaris Therapeutics, Inc. ( NASDAQ:ACRS ) came out with a strong set of second-quarter numbers that could...
Simply Wall St.Aclaris Therapeutics Second Quarter 2024 Earnings: Beats Expectations
Aclaris Therapeutics ( NASDAQ:ACRS ) Second Quarter 2024 Results Key Financial Results Revenue: US$2.77m (up 48% from...
© 2024 Yahoo. All rights reserved.